Haemonetics Corp. buy Citigroup Inc.
Start price
09.07.25
/
50%
€65.00
Target price
09.07.26
€76.78
Performance (%)
-33.23%
Price
07.11.25
€59.50
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Haemonetics Corp. is performing very badly with a performance of -33.23%. This prediction currently runs until 09.07.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | - | - |
| iShares Core DAX® | -0.917% | -2.585% |
| iShares Nasdaq 100 | -3.301% | 1.620% |
| iShares Nikkei 225® | -4.194% | 4.289% |
| iShares S&P 500 | -1.866% | 0.992% |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€41.40
07.10.25
07.10.25
€54.71
07.10.26
07.10.26
20.77%
07.11.25
07.11.25
